Open AccessAnemia is a Prognostic Factor for Overall Survival Rate in Patients with Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Author(s) -
Hidekazu Tanaka,
Taiki Ono,
Yuki Manabe,
Miki Kajima,
Koya Fujimoto,
Yuki Yuasa,
Takehiro Shiinoki,
Yoshikazu Yamaji,
Kazuto Matsunaga
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s336044
Subject(s) - medicine , anemia , lung cancer , body mass index , multivariate analysis , radiation therapy , chemoradiotherapy , univariate analysis , gastroenterology , hemoglobin , oncology , cancer , stage (stratigraphy) , survival rate , surgery , paleontology , biology
Anemia has been associated with poor prognosis in patients with cancer across several cancer types. It has been identified as a prognostic factor in patients with non-small cell lung cancer (NSCLC) who have undergone surgery or chemoradiotherapy. However, there are only a few reports that have evaluated the prognostic significance of anemia in patients with NSCLC undergoing stereotactic body radiation therapy (SBRT).